Covestor
PACB icon

Covestor’s Pacific Biosciences PACB Stock Holding History

Covestor’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
89
-58
-39% -$82 ﹤0.01% 2709
2026
Q2 		$0 Buy
147
+104
+242% +$151 ﹤0.01% 2751
2026
Q1 		$0 Hold
43
– – ﹤0.01% 2641
2025
Q4 		$0 Sell
43
-1
-2% -$2 ﹤0.01% 2615
2025
Q3 		$0 Hold
44
– – ﹤0.01% 2631
2025
Q2 		$0 Sell
44
-3
-6% -$3 ﹤0.01% 2605
2025
Q1 		$0 Hold
47
– – ﹤0.01% 2590
2024
Q4 		$0 Sell
47
-16
-25% -$31 ﹤0.01% 2596
2024
Q3 		$0 Sell
63
-3
-5% -$5 ﹤0.01% 2600
2024
Q2 		$0 Buy
66
+41
+164% +$83 ﹤0.01% 2610
2024
Q1 		$0 Buy
25
+11
+79% +$64 ﹤0.01% 2597
2023
Q4 		$0 Sell
14
-1
-7% -$8 ﹤0.01% 2553
2023
Q3 		$0 Sell
15
-7
-32% -$80 ﹤0.01% 2541
2023
Q2 		$0 Hold
22
– – ﹤0.01% 2499
2023
Q1 		$0 Hold
22
– – ﹤0.01% 2423
2022
Q4 		$0 Sell
22
-2
-8% -$17 ﹤0.01% 2451
2022
Q3 		$0 Sell
24
-4
-14% -$23 ﹤0.01% 2415
2022
Q2 		$0 Sell
28
-8
-22% -$49 ﹤0.01% 2228
2022
Q1 		$0 Sell
36
-198
-85% -$2.28K ﹤0.01% 2340
2021
Q4 		$5K Buy
+234
New +$5.65K 0.01% 1329

Other funds holding PACB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Bourne Lent Asset Management
Bourne Lent Asset Management Pawling, New York $293M AUM 24.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Carret Asset Management
Carret Asset Management New York $1.14B AUM 25.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Covestor's PACB Position: Q3 2026 in Review

Covestor reduced its Pacific Biosciences (PACB) stake by 39% in Q3 2026, selling an estimated $82 and leaving 89 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

Covestor first reported a position in PACB in Q4 2021 and has held it in 20 quarters since. The position peaked at $5K in Q4 2021. 67 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Covestor held 89 shares of Pacific Biosciences worth $0 as of Q3 2026.
  • Covestor sold 58 Pacific Biosciences shares in Q3 2026, an estimated $82.
  • Pacific Biosciences made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2709 holding.
  • Covestor first reported a position in Pacific Biosciences in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Pacific Biosciences position peaked at $5K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.